PS-066 Infusion reactions documented with different generic paclitaxel formulations by means of an adverse drug reactions reporting programme
PS-066 Infusion reactions documented with different generic paclitaxel formulations by means of an adverse drug reactions reporting programme is a paper indexed in ScholarIQ from OpenAlex.
How many citations does PS-066 Infusion reactions documented with different generic paclitaxel formulations by means of an adverse drug reactions reporting programme have?
PS-066 Infusion reactions documented with different generic paclitaxel formulations by means of an adverse drug reactions reporting programme has 1 citations in the OpenAlex counts ScholarIQ stores.
When was PS-066 Infusion reactions documented with different generic paclitaxel formulations by means of an adverse drug reactions reporting programme published?
PS-066 Infusion reactions documented with different generic paclitaxel formulations by means of an adverse drug reactions reporting programme has 2016 year in the ScholarIQ index.
What is the open-access status of PS-066 Infusion reactions documented with different generic paclitaxel formulations by means of an adverse drug reactions reporting programme?
PS-066 Infusion reactions documented with different generic paclitaxel formulations by means of an adverse drug reactions reporting programme has closed oa status in the ScholarIQ index.
What is the DOI of PS-066 Infusion reactions documented with different generic paclitaxel formulations by means of an adverse drug reactions reporting programme?
The DOI for PS-066 Infusion reactions documented with different generic paclitaxel formulations by means of an adverse drug reactions reporting programme is on the source record.
What is the OpenAlex record for PS-066 Infusion reactions documented with different generic paclitaxel formulations by means of an adverse drug reactions reporting programme?
The OpenAlex for PS-066 Infusion reactions documented with different generic paclitaxel formulations by means of an adverse drug reactions reporting programme is on the source record.